SevenBridge Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Sell |
37,763
-945
| -2% | -$25.2K | 0.16% | 116 |
|
|
2025
Q4 | $1M | Sell |
38,708
-19,231
| -33% | -$485K | 0.16% | 115 |
|
|
2025
Q3 | $1.5M | Sell |
57,939
-19,140
| -25% | -$472K | 0.25% | 98 |
|
|
2025
Q2 | $1.9M | Sell |
77,079
-23,259
| -23% | -$542K | 0.34% | 94 |
|
|
2025
Q1 | $2.32M | Sell |
100,338
-31,306
| -24% | -$819K | 0.46% | 75 |
|
|
2024
Q4 | $3.36M | Sell |
131,644
-37,323
| -22% | -$1.01M | 0.64% | 51 |
|
|
2024
Q3 | $4.43M | Buy |
168,967
+7,992
| +5% | +$233K | 0.85% | 32 |
|
|
2024
Q2 | $4.72M | Buy |
160,975
+3,752
| +2% | +$103K | 1.04% | 27 |
|
|
2024
Q1 | $4.37M | Buy |
157,223
+5,853
| +4% | +$162K | 0.99% | 28 |
|
|
2023
Q4 | $4.36M | Buy |
151,370
+8,127
| +6% | +$246K | 1.03% | 25 |
|
|
2023
Q3 | $4.75M | Buy |
143,243
+7,382
| +5% | +$261K | 1.23% | 21 |
|
|
2023
Q2 | $4.98M | Buy |
135,861
+3,434
| +3% | +$134K | 1.29% | 20 |
|
|
2023
Q1 | $5.4M | Buy |
132,427
+3,231
| +3% | +$140K | 1.49% | 18 |
|
|
2022
Q4 | $6.62M | Buy |
129,196
+3,152
| +3% | +$151K | 1.94% | 11 |
|
|
2022
Q3 | $5.52M | Buy |
126,044
+30,046
| +31% | +$1.46M | 1.87% | 12 |
|
|
2022
Q2 | $5.03M | Sell |
95,998
-171
| -0.2% | -$8.71K | 2.04% | 9 |
|
|
2022
Q1 | $4.98M | Sell |
96,169
-4,960
| -5% | -$257K | 1.75% | 13 |
|
|
2021
Q4 | $5.97M | Buy |
101,129
+2,266
| +2% | +$112K | 1.81% | 14 |
|
|
2021
Q3 | $4.25M | Buy |
98,863
+217
| +0.2% | +$9.61K | 1.42% | 15 |
|
|
2021
Q2 | $3.86M | Buy |
98,646
+3,163
| +3% | +$123K | 1.26% | 21 |
|
|
2021
Q1 | $3.46M | Buy |
95,483
+746
| +0.8% | +$26.5K | 1.26% | 24 |
|
|
2020
Q4 | $3.49M | Sell |
94,737
-2,116
| -2% | -$77.6K | 1.36% | 23 |
|
|
2020
Q3 | $3.37M | Buy |
96,853
+3,516
| +4% | +$123K | 1.53% | 19 |
|
|
2020
Q2 | $2.9M | Buy |
93,337
+3,390
| +4% | +$115K | 1.44% | 22 |
|
|
2020
Q1 | $2.79M | Sell |
89,947
-3,389
| -4% | -$115K | 1.61% | 19 |
|
|
2019
Q4 | $3.47M | Sell |
93,336
-479
| -0.5% | -$17.1K | 0.91% | 22 |
|
|
2019
Q3 | $3.2M | Buy |
93,815
+4,358
| +5% | +$158K | 1.68% | 17 |
|
|
2019
Q2 | $3.68M | Buy |
89,457
+1,918
| +2% | +$76.2K | 1.32% | 20 |
|
|
2019
Q1 | $3.53M | Buy |
87,539
+17
| +0% | +$681 | 1.32% | 17 |
|
|
2018
Q4 | $3.63M | Sell |
87,522
-1,285
| -1% | -$53.3K | 2.22% | 7 |
|
|
2018
Q3 | $3.71M | Sell |
88,807
-763
| -0.9% | -$29.4K | 1.97% | 8 |
|
|
2018
Q2 | $3.08M | Buy |
89,570
+2,633
| +3% | +$90K | 1.72% | 10 |
|
|
2018
Q1 | $2.93M | Sell |
86,937
-80
| -0.1% | -$2.75K | 1.68% | 9 |
|
|
2017
Q4 | $2.99M | Buy |
87,017
+192
| +0.2% | +$6.55K | 1.65% | 9 |
|
|
2017
Q3 | $2.94M | Sell |
86,825
-107
| -0.1% | -$3.44K | 1.69% | 10 |
|
|
2017
Q2 | $2.77M | Buy |
86,932
+5,729
| +7% | +$181K | 1.69% | 8 |
|
|
2017
Q1 | $2.63M | Sell |
81,203
-6,762
| -8% | -$213K | 1.73% | 9 |
|
|
2016
Q4 | $2.73M | Hold |
87,965
| – | – | 1.99% | 6 |
|
|
2016
Q3 | $2.73M | Buy |
87,965
+18,325
| +26% | +$613K | 1.99% | 6 |
|
|
2016
Q2 | $2.33M | Sell |
69,640
-35,859
| -34% | -$1.14M | 1.63% | 9 |
|
|
2016
Q1 | $3.38M | Buy |
+105,499
| New | +$3.01M | 0.3% | 28 |
|
Other funds holding PFE
VCM
VPM
SevenBridge Financial Group's PFE Position: Q1 2026 in Review
SevenBridge Financial Group reduced its Pfizer (PFE) stake by 2.4% in Q1 2026, selling an estimated $25.2K and leaving 37,763 shares worth $1.01M. The position accounts for 0.16% of the portfolio, ranked #116.
SevenBridge Financial Group first reported a position in PFE in Q1 2016 and has held it in 41 quarters since. The position peaked at $6.62M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- SevenBridge Financial Group held 37,763 shares of Pfizer worth $1.01M as of Q1 2026.
- SevenBridge Financial Group sold 945 Pfizer shares in Q1 2026, an estimated $25.2K.
- Pfizer made up 0.16% of SevenBridge Financial Group's portfolio in Q1 2026, its #116 holding.
- SevenBridge Financial Group first reported a position in Pfizer in Q1 2016 and has held it in 41 quarters since.
- SevenBridge Financial Group's Pfizer position peaked at $6.62M in Q4 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.